Comparisons
In-depth guides and analysis on comparisons from the Safeguard engineering team.
32 articles
Snyk Competitors: A 2026 Market Map
Snyk popularized developer-first SCA, but the competitive field has broadened into full AppSec platforms. Here's who's actually competing for the same budget in 2026.
Snyk AppRisk: What It Actually Covers
Snyk AppRisk aggregates findings across Snyk's scanners into a single application-level risk view — here's what it covers, and what it doesn't replace.
Snyk's Market Trajectory Under Peter McKay
Peter McKay has led Snyk as CEO since 2020, steering it from a developer-first open-source scanning tool into a broad, AI-integrated application security platform through a string of acquisitions and a sustained enterprise push.
Checkmarx vs Fortify: A Practical Comparison
Checkmarx and Fortify solve the same SAST problem with different architectures — here's how they actually differ on accuracy, deployment, and total cost.
The Snyk Tool: What It Does, and What It Doesn't
The Snyk tool covers SCA, container, and IaC scanning well, but its SAST depth and enterprise pricing are the two things buyers most often get wrong going in.
Checkmarx vs SonarQube: An Honest Comparison
Checkmarx and SonarQube get compared constantly, but they're not really solving the same problem — one is a dedicated security SAST platform, the other is a code-quality tool with a security add-on.
The Gartner Magic Quadrant for Application Security Testing, 2026 Edition
What the Magic Quadrant for Application Security Testing actually measures, how leaders end up in that top-right quadrant, and why the report is one input into a buying decision, not the decision itself.
Snyk's Market Position: An Independent Read Going Into 2026
Snyk's market position going into 2026 rests on developer-first SCA and container scanning, with SAST and DAST as comparatively newer additions.
Self-healing security runs on Safeguard.
Your first fix PR is minutes away.
No sales call required, even your agent can complete the purchase over MCP.